Medtronic is a leader in delivering therapy and procedural innovations to address the major disease states impacting patients and healthcare costs around the world.
In 2012 Medtronic parted ways with the well known Physio-Control Lifepak brand of external defibrillators to refocus it's business in advanced and developing areas of healthcare.
Although no longer manufactured under the Medtronic name. The Medtronic Lifepak series of external defibrillators is well know throughout the industry. These products can still be found professionally refurbished in the aftermarket.
In 2014 the acquisition of Covidien brought an impressive portfolio of industry-leading products that enhance Medtronic’s existing portfolio, offer greater breadth across clinical areas, or create exciting entry points into new therapies.
The combined company offers a broad range of products for healthcare providers: